-
Novaliq Transforms Topical Therapies
Our unique and versatile water-free technology is poised to transform established treatments.
-
Potential to Redefine Dry Eye Disease Drug Therapies with EyeSol®
Our products target key drivers of the disease and have constantly demonstrated significant improvement in sign and symptoms of dry eye in clinical trials.
-
Overcoming Limitations in Eye Care Therapies
Our technology, opens completely new and intriguing opportunities to cure, relief and prevent diseases in various areas of indications for patients.
-
Fast and powerful anti-inflammatory dry eye drug therapy
CyclASol® unfolds the full potential of cyclosporine A on the ocular surface with an unprecedented tolerability profile
-
We are Pioneers
Our team of seasoned industry experts explores the world of water-free therapies to develop best-in-class ocular therapies. We expand into other eye care indications and topical therapeutics spaces.
-
Novel Drug Products Creation with new composition-of-Matter IP
Our technology is a powerful Intellectual Property (IP) engine
Lead product candidates
Our late-stage investigational drug developments provide unique therapeutic options for millions of diagnosed but untreated or undertreated dry eye patients:
Novaliq products
News & Media
Reach more about our latest press releases, key scientific
publications and other company resources